A new era of cosmetic innovation has begun with a spike in demand for non-invasive chin augmentation treatments, driven by the quest for facial harmony and perfect jawline proportions. If you are looking for the latest innovations for giving your clients a perfect chin, you can discover them here.
Non-invasive chin augmentation is one of the most emerging advancements in aesthetic medicine. It paves the way for a safe, effective, and minimally invasive alternative to standard surgical procedures. With the transformative power of dermal fillers, such as hyaluronic acid (HA), individuals can now sculpt and refine their chin’s shape, projection, and symmetry without the need for incisions or downtime.
This evolution in cosmetic enhancement has caught the attention of industry leaders like Galderma, a pioneering force in dermatology. Recently approved by Health Canada, Restylane® SHAYPE™ marks a new era in injectable chin augmentation, offering a revolution in facial aesthetics.
Restylane® SHAYPETM is a revolutionary kind of chin augmentation technology with a bone-mimicking effect to raise the bar. It offers people the confidence and low risk they need to get a flawless facial profile.
Addressing the chin region
When it comes to facial appearance and symmetry, the chin is an important feature. Factors like ageing and genetics can cause a “weak chin” or the impression of a double chin, affecting chin definition. There has been a dearth of non-invasive alternatives to surgical implants, which were formerly the gold standard for fixing these problems.
About NASHA HD™ technology
The groundbreaking NASHA HD™ technology from Galderma powers Restylane® SHAYPE™, making it an exceptional product. This remarkable technology enables Restylane® SHAYPE™ to be the most HA gel obtainable.
Its advanced formulation enables deep injection into the bone, providing unparalleled support and exceptional shaping capabilities. With Restylane® SHAYPE™, aesthetic injectors can achieve natural-looking results by enhancing chin projection and elongation. Its unique properties make it a highly sought-after product in the aesthetic industry.
Clinical validation and patient satisfaction
Pivotal 12-month research conducted across Canada has proven Restylane® SHAYPE™ to be both effective and safe. Even after a year, 91 per cent of patients reported seeing an improvement in their facial aesthetics, indicating their high satisfaction with the results.
Furthermore, an astounding 84 per cent of patients indicated their eagerness to undergo further treatment with Restylane® SHAYPE™. So, overall, in terms of patient satisfaction, it highlights the product’s effectiveness and durability.
Hearing from experts: observing the impacts
Renowned experts, namely Dr Bald Scassellati Sforzolini and Dr Andreas Nikolis, have highlighted the groundbreaking potential of Restylane® SHAYPE™. This innovative treatment offers a non-surgical solution for chin remodelling with the ability to achieve a bone-like look without requiring any downtime.
After extensive development and clinical testing, Galderma has introduced a safe and effective solution that meets a long-standing demand within the aesthetic community.
The looming global expansion
Restylane® SHAYPE™ has been approved in Canada, but reviews are still going on in other places. Galderma dedicates efforts to bringing this new product to markets worldwide, ensuring patients can benefit from its advancements in chin augmentation technology.
To sum up
An innovative new option for non-invasive chin augmentation that makes use of NASHA HD™ technology is Restylane®. It provides good support and shape with a bone-mimicking effect and deep injection capacity for natural-looking results with minimum risk. Clinical studies have demonstrated its effectiveness and safety, with high patient satisfaction rates even after a year of treatment.
Regulators in other regions are currently reviewing it, and Canada is receiving regulatory approval. Galderma dedicates itself to expanding its global reach, ensuring patients worldwide can benefit from its innovative chin augmentation technology.